Sentinel Lymph Node Mapping and Biopsy for Ductal Carcinoma In situ and Other Controversial Indications

Fuhrman, George M.
May 2004
American Surgeon;May2004, Vol. 70 Issue 5, p403
Academic Journal
This review discusses the currently available literature regarding three controversial indications for sentinel node mapping for breast cancer patients. For women with ductal carcinoma in situ (DCIS), the use of sentinel lymph node mapping (SLNM) should be limited to women having a mastectomy. For patients with multifocal breast carcinoma, SLNM is accurate when a retroareolar injection technique is employed in the procedure. When treatment plans for node-negative patients call for neoadjuvant chemotherapy, accurate sentinel node mapping can be performed prior to the administration of chemotherapy. The resolution of these and other controversies should result in the expansion of the number of patients evaluated with SLNM in the future.


Related Articles

  • Sorting Through the Arguments on Breast Screening. Marmot, Michael G. // JAMA: Journal of the American Medical Association;6/26/2013, Vol. 309 Issue 24, p2553 

    The author discusses the Independent United Kingdom (UK) Panel on Breast Screening's contention that the best evidence for the relative benefit of breast cancer screening on mortality reduction is based on randomized controlled trials (RCT) of breast screening. Some medical experts argue that...

  • Rethinking Breast Mountain (Yuam): Surgical Treatments of Breast Cancer in South Korea, 1959-1993. Soyoung Suh // Asia Pacific Perspectives;Fall2016, Vol. 14 Issue 1, p4 

    The paper aims to understand the innovations of surgical treatments of breast cancer in South Korea from 1959-93 and South Korean conceptualization of the breast cancer and discusses the views of Korean women including patient Yi Hyo-suk's on mastectomy.

  • Assessment of clinical response after two cycles of primary chemotherapy in breast cancer. Andreas Makris // Breast Cancer Research & Treatment;May2008, Vol. 109 Issue 2, p337 

    Abstract   Background Complete clinical (cCR) and pathological (pCR) response to neoadjuvant chemotherapy in breast cancer is associated with improved survival. Various imaging and immunological techniques have been tested as predictors of response early in the course of chemotherapy, but...

  • Patterns of sore mouth in outpatients with cancer receiving chemotherapy. Carlton Brown; Susan Beck; Douglas Peterson; Deborah McGuire; William Dudley; Kathleen Mooney // Supportive Care in Cancer;Apr2009, Vol. 17 Issue 4, p413 

    Abstract Goals  The aims of this secondary data analysis were to (a) categorize patterns in the development, duration, intensity, and resolution of sore mouth (which can be considered a proxy for oral mucositis) severity and distress over two cycles of chemotherapy in cancer outpatients...

  • Breast-cancer screening saves lives even though it also picks up cases in some women that would never have caused them a problem, according to a review published in The Lancet medical journal.  // MondayMorning;11/ 5/2012, Vol. 20 Issue 42, p1 

    The article focuses on the importance of routine medical screening in women against breast cancer. It informs that breast cancer screening offers several benefits to women as it can identify other problem that are not diagnosed previously. It further states that screening has prevented about...

  • WAR ON CANCER. Triggs, Charlotte // People;10/25/2010, Vol. 74 Issue 15, p113 

    An article is presented that reports on news correspondent Jennifer Griffin and her experience with breast cancer. The article discusses Griffin's diagnosis and treatment, describing her chemotherapy and mastectomy. Information is also provided on Griffin's family and feelings towards surgery...

  • Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy. Skinner, Heath D.; Strom, Eric A.; Motwani, Sabin B.; Woodward, Wendy A.; Green, Marjorie C.; Babiera, Gildy; Booser, Daniel J.; Meric-Bernstam, Funda; Buchholz, Thomas A. // Radiation Oncology;2013, Vol. 8 Issue 1, p1 

    Background: Radiation is a standard component of treatment for patients with locoregional recurrence (LRR) of breast cancer following mastectomy. The current study reports the results of a 10% radiation dose escalation in these patients. Methods: 159 patients treated at MD Anderson Cancer Center...

  • Young Women with Locally Advanced Breast Cancer Who Achieve Breast Conservation after Neoadjuvant Chemotherapy Have a Low Local Recurrence Rate. SWEETING, RAESHELL S.; KLAUBER-DEMORE, NANCY; MEYERS, MICHAEL O.; DEAL, ALLISON M.; BURROWS, EMILY M.; DROBISH, AMY A.; ANDERS, CAREY K.; CAREY, LISA A. // American Surgeon;Jul2011, Vol. 77 Issue 7, p850 

    Women with locally advanced breast cancer (LABC) who are breast conservation (BCT) candidates after neoadjuvant chemotherapy have the best long-term outcome and low local-regional recurrence (LRR) rates. However, young women are thought to have a higher risk of LRR based on historical data. This...

  • De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer.  // Journal of Translational Medicine;2012, Vol. 10 Issue 1, p42 

    The article presents information on a study which conducts discovery profiling of circulating small RNAs to identify blood-based small RNA markers of breast cancer (BC) clinical outcome. The study analyzed pre-treatment sera of 42 stage II-III locally advanced and inflammatory BC patients who...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics